Deciphera raises $75M in series B

Deciphera Pharmaceuticals LLC (Waltham, Mass.) raised $75 million in a series B round led by New Leaf Venture Partners. The company's undisclosed existing investors also participated.

Deciphera said it has four kinase inhibitors in Phase I testing for cancer indications. The company said each of its molecules block multiple targets, which Deciphera hopes will reduce drug resistance. ...